HGH Gel

Manufacturer: Strike First Nutrition | Apotheca Company
Effective date: 2018-04-20
Label type: HUMAN OTC DRUG LABEL
Version: 2
Source: legacy-cache
Hydrated at: 2026-08-02 00:59:42

Label at a glance#

ProductHGH Gel

Active ingredientSUS SCROFA ADRENAL GLAND, THYROID, BOVINE, SOMATROPIN

Label structure9 sections

Dosage and administration

Apply 1/2 teaspoon, 2 full pumps in the morning and in the evening three weeks on one week off or five days on two days off. Gel should always be applied to the thin areas of skin, for example behind the knees or underarms and locations should be rotated. For intensive use, use twice daily in the morning and at night.

Contacts and useful links#

PhoneLabel contact925-932-1292

Label contents#

Full prescribing information#

ACTIVE INGREDIENTS:

OTC - ACTIVE INGREDIENT SECTION

GLANDULA SUPRARENALIS SUIS 6X, THYROIDINUM (BOVINE) 8X, HGH 30X.

INDICATIONS:

OTC - PURPOSE SECTION

*MAY IMPROVE BONE AND JOINT HEALTH

*MAY INCREASE MUSCLE AND REDUCE FAT

*MAY IMPROVE SLEEP

*MAY STRENGTHEN THE IMMUNE SYSTEM

*These statements have not been evaluated by the FDA

WARNINGS:

WARNINGS SECTION

WARNING: KEEP OUT OF REACH OF CHILDREN

If swallowed, get medical help or contact a Poison Control Center right away.

If pregnant or breast-feeding, ask a health professional before use.

FOR EXTERNAL USE ONLY

Sealed for your protection.

Do not use if seal has been broken or tampered with.

KEEP OUT OF REACH OF CHILDREN:

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

KEEP OUT OF REACH OF CHILDREN.

If swallowed, get medical help or contact a Poison Control Center right away.

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

Apply 1/2 teaspoon, 2 full pumps in the morning and in the evening three weeks on one week off or five days on two days off.

Gel should always be applied to the thin areas of skin, for example behind the knees or underarms and locations should be rotated. For intensive use, use twice daily in the morning and at night.

INDICATIONS:

INDICATIONS & USAGE SECTION

*MAY IMPROVE BONE AND JOINT HEALTH

*MAY INCREASE MUSCLE AND REDUCE FAT

*MAY IMPROVE SLEEP

*MAY STRENGTHEN THE IMMUNE SYSTEM

*These statements have not been evaluated by the FDA

INACTIVE INGREDIENTS:

INACTIVE INGREDIENT SECTION

PURIFIED WATER, PHENOXYETHANOL, CAPRYLYL GLYCOL, SORBIC ACID, SODIUM HYDROXIDE, ACRYLATES/C10-30 ALKYL ACRYLATE CROSSPOLYMER, PEG-33, PEG-8 DIMETHICONE, PEG-14, ALOE BARBADENSIS LEAF JUICE, ALOE VERA (LEAF)*, GREEN TEA (LEAF)*, LICORICE (ROOT)*, CHASTE TREE (FRUIT)*, EPIMEDIUM (LEAF)*, GINKGO (LEAF)*, VELVET BEAN (SEED)*, WILD YAM (ROOT)*, ASCORBIC ACID (VITAMIN C), TOCOPHEROLS (SOY), EDETATE DISODIUM, NATURAL PLANT EXTRACT, POTASSIUM SORBATE. *EXTRACT

QUESTIONS:

OTC - QUESTIONS SECTION

Distributed By:

Strike First Nutrition

2638 Pleasant Hill Rd,

Pleasant Hill, CA 94523

925-932-1292

StrikeFirstNutrition.com

StrikeFirstNutrition.net

PACKAGE LABEL DISPLAY:

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

STRIKEFIRST
NUTRITION
Platinum Series
HGH
Gel ANTI AGING
MAXIMUM STRENGTH
HOMEOPATHIC
HUMAN GROWTH HORMONE
PARABEN AND SLS FREE
NET WT. 3.5 OZ (100G)

HGH Gel

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
SOMATROPIN	ACTIVE INGREDIENT	NQX9KB6PCL	1
SUS SCROFA ADRENAL GLAND	ACTIVE INGREDIENT	398IYQ16YV	1
THYROID, BOVINE	ACTIVE INGREDIENT	MN18OTN73W	1
SOMATROPIN	ACTIVE MOIETY	NQX9KB6PCL	1
SUS SCROFA ADRENAL GLAND	ACTIVE MOIETY	398IYQ16YV	1
THYROID, BOVINE	ACTIVE MOIETY	MN18OTN73W	1
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	1
ASCORBIC ACID	INACTIVE INGREDIENT	PQ6CK8PD0R	1
CAPRYLYL GLYCOL	INACTIVE INGREDIENT	00YIU5438U	1
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED)	INACTIVE INGREDIENT	59TL3WG5CO	1
CHASTE TREE	INACTIVE INGREDIENT	433OSF3U8A	1
DIOSCOREA VILLOSA TUBER	INACTIVE INGREDIENT	IWY3IWX2G8	1
EDETATE DISODIUM	INACTIVE INGREDIENT	7FLD91C86K	1
EPIMEDIUM SAGITTATUM TOP	INACTIVE INGREDIENT	7G8Y7M4D58	1
GINKGO	INACTIVE INGREDIENT	19FUJ2C58T	1
GREEN TEA LEAF	INACTIVE INGREDIENT	W2ZU1RY8B0	1
LICORICE	INACTIVE INGREDIENT	61ZBX54883	1
MUCUNA PRURIENS SEED	INACTIVE INGREDIENT	55G8SQ543S	1
OREGANO	INACTIVE INGREDIENT	0E5AT8T16U	1
PEG-8 DIMETHICONE	INACTIVE INGREDIENT	GIA7T764OD	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	1
POLYETHYLENE GLYCOL 1500	INACTIVE INGREDIENT	1212Z7S33A	1
POLYETHYLENE GLYCOL 700	INACTIVE INGREDIENT	762678AC5R	1
POTASSIUM SORBATE	INACTIVE INGREDIENT	1VPU26JZZ4	1
SODIUM HYDROXIDE	INACTIVE INGREDIENT	55X04QC32I	1
SORBIC ACID	INACTIVE INGREDIENT	X045WJ989B	1
TOCOPHEROL	INACTIVE INGREDIENT	R0ZB2556P8	1
WATER	INACTIVE INGREDIENT	059QF0KO0R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 27 matching rows.

HGH Gel
Glandula Suprarenalis Suis, Thyroidinum (Bovine), HGH
SUS SCROFA ADRENAL GLAND
THYROID, BOVINE
SOMATROPIN
WATER
PHENOXYETHANOL
CAPRYLYL GLYCOL
SORBIC ACID
SODIUM HYDROXIDE
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED)
POLYETHYLENE GLYCOL 1500
PEG-8 DIMETHICONE
POLYETHYLENE GLYCOL 700
ALOE VERA LEAF
GREEN TEA LEAF
LICORICE
CHASTE TREE
EPIMEDIUM SAGITTATUM TOP
GINKGO
MUCUNA PRURIENS SEED
DIOSCOREA VILLOSA TUBER
ASCORBIC ACID
TOCOPHEROL
EDETATE DISODIUM
OREGANO
POTASSIUM SORBATE

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
61877-0002	61877-0002-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 25 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
SUS SCROFA ADRENAL GLAND	398IYQ16YV	ACTIB
THYROID, BOVINE	MN18OTN73W	ACTIB
SOMATROPIN	NQX9KB6PCL	ACTIB
WATER	059QF0KO0R	IACT
PHENOXYETHANOL	HIE492ZZ3T	IACT
CAPRYLYL GLYCOL	00YIU5438U	IACT
SORBIC ACID	X045WJ989B	IACT
SODIUM HYDROXIDE	55X04QC32I	IACT
CARBOMER INTERPOLYMER TYPE A (ALLYL SUCROSE CROSSLINKED)	59TL3WG5CO	IACT
POLYETHYLENE GLYCOL 1500	1212Z7S33A	IACT
PEG-8 DIMETHICONE	GIA7T764OD	IACT
POLYETHYLENE GLYCOL 700	762678AC5R	IACT
ALOE VERA LEAF	ZY81Z83H0X	IACT
GREEN TEA LEAF	W2ZU1RY8B0	IACT
LICORICE	61ZBX54883	IACT
CHASTE TREE	433OSF3U8A	IACT
EPIMEDIUM SAGITTATUM TOP	7G8Y7M4D58	IACT
GINKGO	19FUJ2C58T	IACT
MUCUNA PRURIENS SEED	55G8SQ543S	IACT
DIOSCOREA VILLOSA TUBER	IWY3IWX2G8	IACT
ASCORBIC ACID	PQ6CK8PD0R	IACT
TOCOPHEROL	R0ZB2556P8	IACT
EDETATE DISODIUM	7FLD91C86K	IACT
OREGANO	0E5AT8T16U	IACT
POTASSIUM SORBATE	1VPU26JZZ4	IACT

Source Document#

Source XML · Source PDF

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 6 · 331 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
ASCORBIC ACID	ASCORBIC ACID	PQ6CK8PD0R	GEL / TOPICAL		7 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
ASCORBIC ACID	ASCORBIC ACID	PQ6CK8PD0R	TABLET / ORAL		80 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SOLUTION / INTRAMUSCULAR		78 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SHAMPOO, SUSPENSION / TOPICAL	1 %w/w		Exact identifier — unii candidate 77 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	AEROSOL, FOAM / TOPICAL	0.05 %w/w		Exact identifier — unii candidate 77 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	TABLET, DELAYED RELEASE / ORAL		4 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	INJECTION, SUSPENSION / INTRA-ARTICULAR		1 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRAPLEURAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	TABLET, COATED / ORAL	NA		Exact identifier — unii candidate 19 equally ranked IID candidates
ASCORBIC ACID	ASCORBIC ACID	PQ6CK8PD0R	SYRUP / ORAL		200 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
ASCORBIC ACID	ASCORBIC ACID	PQ6CK8PD0R	TABLET, FILM COATED / ORAL	20 mg		Exact identifier — unii candidate 25 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRATHECAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SORBIC ACID	SORBIC ACID	X045WJ989B	TABLET, FILM COATED / ORAL		5 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	CAPSULE, COATED PELLETS / ORAL	0.01 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	GRANULE, FOR SUSPENSION / ORAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	INJECTION / INTRABURSAL	0.01 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	INJECTION, SOLUTION / INTRAMUSCULAR		4 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
ASCORBIC ACID	ASCORBIC ACID	PQ6CK8PD0R	SUSPENSION / ORAL		520 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION, EXTENDED RELEASE / INTRALESIONAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRA-ARTERIAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	LIQUID / INTRAVENOUS	0.03 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
SORBIC ACID	SORBIC ACID	X045WJ989B	SOLUTION / OPHTHALMIC	0.2 %w/v		Exact identifier — unii candidate 19 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, SUSPENSION / INTRASYNOVIAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
ASCORBIC ACID	ASCORBIC ACID	PQ6CK8PD0R	SOLUTION / TOPICAL	0.04 %w/w		Exact identifier — unii candidate 25 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVITARY	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, FOR SOLUTION / INTRA-ARTERIAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	INJECTION / INTRAVENOUS	10 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, FOR SOLUTION / PARENTERAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SOLUTION / AURICULAR (OTIC)	0.1 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	GEL / VAGINAL		20 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SUSPENSION / ENDOTRACHEAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	INJECTION / INFILTRATION		6 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	GRANULE, FOR SUSPENSION / ORAL		80 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SOLUTION / ORAL		432 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	TABLET, CHEWABLE / ORAL		1 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / TOPICAL		39 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	TABLET, EXTENDED RELEASE / ORAL		13 mg	Exact identifier — unii candidate 174 equally ranked IID candidates
ASCORBIC ACID	ASCORBIC ACID	PQ6CK8PD0R	INJECTION, POWDER, FOR SOLUTION / INTRAVENOUS	2 mg		Exact identifier — unii candidate 25 equally ranked IID candidates
SORBIC ACID	SORBIC ACID	X045WJ989B	SYRUP / ORAL		80 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	TABLET / ORAL		6 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRADERMAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SYRUP / ORAL	71 mg/5ml		Exact identifier — unii candidate 174 equally ranked IID candidates
ASCORBIC ACID	ASCORBIC ACID	PQ6CK8PD0R	CAPSULE / ORAL	7 mg		Exact identifier — unii candidate 25 equally ranked IID candidates
POTASSIUM SORBATE	POTASSIUM SORBATE	1VPU26JZZ4	CONCENTRATE / ORAL		1 mg	Exact identifier — unii candidate 19 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS	78.36 mg		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION/ DROPS / AURICULAR (OTIC)	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	PASTE / DENTAL	0.6 %w/w		Exact identifier — unii candidate 174 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	INJECTION / SOFT TISSUE	0.05 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
TOCOPHEROL	TOCOPHEROL	R0ZB2556P8	CAPSULE / ORAL	NA		Exact identifier — unii candidate 5 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	INJECTION, SOLUTION / INTRAVENOUS		7 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SYRUP / ORAL		40 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / EPIDURAL	ADJ PH		Exact identifier — unii candidate 174 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SOLUTION/ DROPS / OPHTHALMIC	0.13 %w/v		Exact identifier — unii candidate 77 equally ranked IID candidates
EDETATE DISODIUM	EDETATE DISODIUM	7FLD91C86K	SPRAY / NASAL		1 mg	Exact identifier — unii candidate 77 equally ranked IID candidates
ASCORBIC ACID	ASCORBIC ACID	PQ6CK8PD0R	CAPSULE, DELAYED RELEASE / ORAL		12 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
PHENOXYETHANOL	PHENOXYETHANOL	HIE492ZZ3T	CREAM, AUGMENTED / TOPICAL		10 mg	Exact identifier — unii candidate 6 equally ranked IID candidates
ASCORBIC ACID	ASCORBIC ACID	PQ6CK8PD0R	INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS		1440 mg	Exact identifier — unii candidate 25 equally ranked IID candidates
POLYETHYLENE GLYCOL 1500	POLYETHYLENE GLYCOL 1600	1212Z7S33A	SOLUTION / TOPICAL	29.7 %w/w		Exact identifier — unii candidate 6 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	SOLUTION / AURICULAR (OTIC)	0.8 %w/w		Exact identifier — unii candidate 174 equally ranked IID candidates
SODIUM HYDROXIDE	SODIUM HYDROXIDE	55X04QC32I	INJECTION / INTRATHECAL	176 mg		Exact identifier — unii candidate 174 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
ade00238-8cb5-4ed3-bfae-0ca989be16c6			0c6338df-e225-4894-9e73-6fdc4a2e6781	2018-04-20	Warnings	Exact identifier spl id: ade00238-8cb5-4ed3-bfae-0ca989be16c6 spl set id: 0c6338df-e225-4894-9e73-6fdc4a2e6781

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.